Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary ciliary dyskinesia: evolution of pulmonary function

J Hellinckx1, M Demedts, K De Boeck

  • 1Department of Paediatrics, Herestraat, Leuven, Belgium.

European Journal of Pediatrics
|June 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same journal

Cost-benefit analysis of nirsevimab for respiratory syncytial virus prevention in infants: a population-based study.

European journal of pediatrics·2026
Same journal

Consensus statement on the use of standardized early mobilization in pediatric patients admitted to pediatric intensive care units in Italy.

European journal of pediatrics·2026
Same journal

Ultrasound-guided midline catheters in the neonatal intensive care unit: a single-center pilot study.

European journal of pediatrics·2026
Same journal

Gastrointestinal pathogens in paediatric patients with diarrhoea during the COVID-19 pandemic in Spain: a multicentre molecular-based prospective study.

European journal of pediatrics·2026
Same journal

Low serum immunoglobulin levels in pediatric atopic dermatitis: association with disease severity and exploratory scores.

European journal of pediatrics·2026
Same journal

Safely developing respiratory care during emergency neonatal transport through systematic collection and analysis of detailed ventilator data.

European journal of pediatrics·2026
See all related articles

Patients with primary ciliary dyskinesia exhibit partially reversible obstructive airway disease at diagnosis. Regular follow-up and therapy show no further lung function decline, indicating a stable prognosis for most.

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Respiratory Diseases

Background:

  • Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting cilia function.
  • It leads to impaired mucus clearance and chronic respiratory infections.
  • Understanding lung function changes in PCD is crucial for management.

Purpose of the Study:

  • To assess pulmonary function in patients with primary ciliary dyskinesia.
  • To evaluate the reversibility of obstructive airway disease in PCD.
  • To determine the long-term lung function evolution in PCD patients under regular follow-up and therapy.

Main Methods:

  • Pulmonary function tests (spirometry) were conducted on 11 patients with PCD.
  • Tests included vital capacity (VC), forced expiratory volume in 1 second (FEV1), and residual volume.

Related Experiment Videos

  • Bronchodilator response to salbutamol was assessed.
  • Longitudinal lung function data was analyzed for 10 older patients over 3-20 years.

    • Main Results:

    • Patients presented with obstructive lung disease: VC 75% predicted, FEV1 63% predicted, RV 169% predicted.
    • A mean FEV1 increase of 13.2% was observed post-salbutamol, indicating partial reversibility.
    • Long-term follow-up showed stable FEV1 and increased VC during childhood and adolescence in most patients.
    • Only 2 patients demonstrated unfavorable lung function evolution.

    Conclusions:

    • PCD patients have partially reversible obstructive airway disease at diagnosis.
    • Regular follow-up and therapy appear to prevent further lung function decline.
    • Prognosis may be poorer in patients with co-existing immunodeficiency or significant initial lung damage.